Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Intrathecal baclofen in multiple sclerosis.
Noise in multiple sclerosis: unwanted and necessary.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Quantifying progression of multiple sclerosis via classification of depth videos.
Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors.
Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes' stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis.
Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors.
Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis.
Myelination Is Associated with Processing Speed in Early Childhood: Preliminary Insights.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Comparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Bringing CLARITY to gray matter atrophy.
The Association of Depression with Pain-Related Treatment Utilization in Patients with Multiple Sclerosis.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Progression in multiple sclerosis is associated with low endogenous NCAM.
Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Pages
« first
‹ previous
…
418
419
420
421
422
423
424
425
426
…
next ›
last »